BESTSTUDY EDU (03978) plans to repurchase and cancel 30 million shares to the trustee.
The Excellence Education Group (03978) announced that the company plans to repurchase and cancel 30 million shares directly from the restricted stock unit plan trustee in the second half of the year. This represents approximately 3.54% of the total number of shares issued by the company as of the date of this announcement, but these repurchased shares have not yet been granted to any designated participants.
BESTSTUDY EDU (03978) announced that the company plans to repurchase and cancel 30 million shares directly from the trust of restricted share units in the second half of the year. This represents approximately 3.54% of the total issued shares of the company as of the date of the announcement, but these repurchased shares have not been allocated to any specific participants.
The board believes that the current stock price of the company severely undervalues its true worth, and sees the repurchase and cancellation as an opportunity to enhance shareholder returns. The board believes that the buyback of shares will increase the net asset value per share and/or earnings per share, effectively enhancing the investment returns for shareholders and strengthening investor confidence in the company, aligning with the overall interests of the company and its shareholders.
The buyback of shares will not have any significant adverse impact on the company's business operations, profitability, financial condition, or debt repayment ability. It will not affect the public float of the company as required by listing rules, nor will it lead to non-compliance with the conditions of a listed company or the company's listing status.
Related Articles

On July 3, AIRDOC-B (02251) spent 353,000 Hong Kong dollars to repurchase 31,900 shares.

FIN STREET SEC(01476): Luo Guohua appointed as non-executive director

SINOMAB BIO-B(03681): Liang Fang appointed as Executive Director of the Company.
On July 3, AIRDOC-B (02251) spent 353,000 Hong Kong dollars to repurchase 31,900 shares.

FIN STREET SEC(01476): Luo Guohua appointed as non-executive director

SINOMAB BIO-B(03681): Liang Fang appointed as Executive Director of the Company.

RECOMMEND





